Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

HLA-DRA Antikörper (AA 26-221)

HLA-DRA Reaktivität: Kaninchen WB, IHC, IP, ICC Wirt: Meerschweinchen Polyclonal unconjugated
Produktnummer ABIN1859814
  • Target Alle HLA-DRA Antikörper anzeigen
    HLA-DRA (HLA Class II DR alpha (HLA-DRA))
    Bindungsspezifität
    • 8
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    AA 26-221
    Reaktivität
    • 90
    • 17
    • 10
    • 10
    • 9
    • 9
    • 3
    • 2
    • 2
    • 1
    Kaninchen
    Wirt
    • 57
    • 48
    • 1
    • 1
    Meerschweinchen
    Klonalität
    • 57
    • 50
    Polyklonal
    Konjugat
    • 55
    • 12
    • 5
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Dieser HLA-DRA Antikörper ist unkonjugiert
    Applikation
    • 49
    • 49
    • 35
    • 33
    • 18
    • 12
    • 11
    • 10
    • 9
    • 5
    • 3
    • 3
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
    Verwendungszweck
    Polyclonal Antibody to HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA)
    Sequenz
    MGHHHHHHSG S- AIKEE HVIIQAEYFL SPDDLGEFMF DFDGDEIFHV DMDKKETVWR LKEFGQFASF EAQGALANIA VDRANLDIMI KRSNHTPDTN VPPEVTLLPS SPVELGEPNV LICFIDKFSP PVINVTWLRN GNPVTMGVSE TVFLPRDDHL FRKFHYLPFL PSTEDVYDCK VEHWGLEEPT LKHWEFEART PLPETTENVV C
    Spezifität
    The antibody is a cavia polyclonal antibody raised against HLA-DRA. It has been selected for its ability to recognize HLA-DRA in immunohistochemical staining and western blotting.
    Aufreinigung
    Antigen-specific affinity chromatography followed by Protein A affinity chromatography
    Immunogen
    Recombinant HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA) corresdonding to Ala26~Cys221 (Accession # NM_001171118.1)
    Isotyp
    IgG
    Top Product
    Discover our top product HLA-DRA Primärantikörper
  • Applikationshinweise

    Western blotting: 0.5-5 μg/mL Immunohistochemistry: 5-20 μg/mL Immunocytochemistry: 5-20 μg/mL Optimal working dilutions must be determined by end user.

    Kommentare

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    Lot specific
    Buffer
    0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
    Handhabung
    Avoid repeated freeze/thaw cycles
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
    Haltbarkeit
    24 months
  • Target
    HLA-DRA (HLA Class II DR alpha (HLA-DRA))
    Andere Bezeichnung
    HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA Produkte)
    Synonyme
    HLA-DRA1 antikoerper, MLRW antikoerper, DR-alpha antikoerper, HLA-DRA antikoerper, Mamu-DRA1 antikoerper, major histocompatibility complex, class II, DR alpha L homeolog antikoerper, major histocompatibility complex, class II, DR alpha antikoerper, hla-dra.L antikoerper, HLA-DRA antikoerper, MAMU-DRA antikoerper, BOLA-DRA antikoerper
    Hintergrund
    MHCDRa, HLADRa, Major Histocompatibility Complex Class II DR Alpha
    Pathways
    T-Zell Rezeptor Signalweg, CXCR4-mediated Signaling Events
Sie sind hier:
Kundenservice